Potential Drug-Drug Interactions and Adverse Drug Reactions associated with Azithromycin used in the treatment of COVID-19 Infected Patients: A Drug Information Resources-Based Review
Clicks: 3
ID: 311261
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #30 of 34 articles by views in Journal of Clinical Advances and Research Reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The end of 2019 became the most remarkable one in human history with the start of an epidemic in Wuhan city of China. The severe respiratory syndrome caused by COVID-19 (named as SARS-CoV-2) created a crisis for public well-being internationally, and the WHO had to declare it a pandemic by March 12, 2020. Many trials are being carried out to check the efficiency and safety of the drugs and treatments. Some of the commonly used drugs are LopinavirRitonavir, Tocilizumab, azithromycin, Hydroxychloroquine, and Convalescent plasma. The drug Hydroxychloroquine, which gave good results earlier, now has restricted use due to a lack of usefulness, but the usage of azithromycin is continued. Micromedex® drug Interaction tool analysis to evaluate and identify Azithromycinrelated possible Drug Drug interactions. Azithromycin tablet highlights the warnings of possible health hazards associated with the administration of Azithromycin along with Precautions in certain co-morbidities and contraindicated patients. The complications with the use of Azithromycin are mostly associated with cardiac functioning; therefore, while selecting of drug, patient ECG should be ruled out before initiation of therapy. A major proportion of patients are asymptomatic; therefore, blind use of Azithromycin should be prohibited. Considering DDIs and ADRs associated with Azithromycin use, it should be used under clinical care with emphasizing proper screening in cardiovascular comorbid patients and those with liver dysfunction.
| Reference Key |
imported_1770374191_6985c42f54f62
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Mohammad Daud Ali, Munfis Patel, Nuzhat Banu, Md. Sarfaraz Alam, Latha Kannan, Md. Salahuddin Ansari, Sarfaraz Ahmad* |
| Journal | Journal of Clinical Advances and Research Reviews |
| Year | 2025 |
| DOI |
10.62896/jcarr.v2.i2.04
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.